• Title: Safe and Effective Medicines for Children: Pediatric Studies Conducted Under the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act
  • Released: 2013-04-03
  • Language: English
  • Pages: 408
  • ASIN: B00C6C76FC

The Best Pharmaceuticals for Children Act (BPCA) and the Pediatric Research Equity Act (PREA) were designed to encourage more pediatric studies of drugs used for children. The FDA asked the IOM to review aspects of pediatric studies and changes in product labeling that resulted from BPCA and PREA and their predecessor policies, as well as assess the incentives for pediatric studies of biologics and the extent to which biologics have been studied in children. The IOM committee concludes that these policies have helped provide clinicians who care for children with better information about the efficacy, safety, and appropriate prescribing of drugs. The IOM suggests that more can be done to increase knowledge about drugs used by children and thereby improve the clinical care, health, and well-being of the nation's children.

I was skeptical at first but Midnighty really came through. They answered all my questions and made the whole experience a plesant one.

Elizabeth Maddry
Richland, Georgia

Why Midnighty?

Focused

Simply focused results for teams of all sizes.

Mature

Midnighty is inherently mature and community centric. It's time for the mature community to have a voice.

Hip

Finding a hip fit just got a whole lot easier.

When my friends need new midnights there's only one word I tell them, Midnighty.

Arriana Atkinson
Weed, California

Meet the Midnighty team

Juan Pablo Montoya

Isabell Leakes

International Sales

Kyle Zimmerman

Sarah Licari

Warehouse Supervisor

Cheryl Collins

Santana White

Customer Experience

Juan Pablo Montoya

Ivan Lashway

Finance

Midnighty is like Tinder... but for midnights!

Valerie Ingersoll
Centerville, Iowa

As Seen On